ARTICLE | Clinical News
Durezol regulatory update
June 30, 2008 7:00 AM UTC
FDA approved an NDA from Sirion for Durezol difluprednate to treat postoperative ocular inflammation and pain. The company plans to launch the topical ophthalmic steroid in 4Q08. Sirion has U.S. right...